补充抑制剂治疗与胸腺瘤相关的骨髓灰质炎:一个现实世界的经验
Sofia Marini1, Carmen Erra2, Laura Fionda3
1Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Frontiers in immunology
|April 29, 2025
概括
补充抑制剂 (CI) 显著改善了胸腺瘤相关的肌痛性肌痛症 (TAMG) 患者的结局,显示出一种类固醇节约效应. 这为这种难以治疗的肌痛性骨髓灰质炎 (MG) 亚群提供了有前途的治疗途径.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 胸腺瘤相关的肌痛性肌痛症 (TAMG) 呈现严重的症状,对标准治疗反应不佳.
- 在临床试验中,TAMG患者的代表性不足,这限制了基于证据的治疗指南.
- 这项研究调查了补充抑制剂 (CI) 在TAMG群体中的疗效.
研究的目的:
- 评估补充抑制剂 (CI) 在治疗胸腺瘤相关的严重肌痛性肌痛症 (TAMG) 的有效性.
- 为了评估TAMG患者接受CI的临床结果,与没有胸腺瘤的骨髓质疏松症 (MG) 患者的对照组进行比较.
主要方法:
- 以CI治疗的23名TAMG患者的回顾性审查 (至少六个月的随访).
- 包括22名没有胸腺瘤的MG患者作为对照组,也接受了CI治疗.
- 使用Myasthenia Gravis-日常生活活动 (MG-ADL) 和量化Myasthenia Gravis (QMG) 评分在基线,3个月和6个月测量的临床结果.
主要成果:
- 从11到3 (3个月) 和4 (6个月) 的MG-ADL中位数显著降低 (p<0.001).
- 中位数QMG分数显著减少,从16到10 (3个月) 和10 (6个月) (p<0.001).
- 在20名患者中降低了普雷尼松剂量,表明了类固醇节约作用;在TAMG和非胸腺瘤MG组之间没有发现显著差异.
结论:
- 补充抑制剂 (CI) 在改善TAMG患者的临床评分方面表现出显著的有效性.
- CI提供了有价值的类固醇节约效果,有利于管理TAMG.
- CI代表了对具有挑战性的TAMG亚群的潜在有效治疗方法.
相关概念视频
Myasthenia Gravis: Overview and Treatment
943
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
943
Myasthenia Gravis: Diagnostic Tests
531
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
531
Disorders of the Skeletal Muscle
826
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
826
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397


